Skip to Main Content

Author Details

Michael P O'Connell
National Institute of Allergy and Infectious Diseases, National Institutes of Health
2007
40
24
PMIDPaper TitleJournal TitlePublished Year
35197435Resolving the genetics of human tryptases: implications for health, disease, and clinical use as a biomarker.Curr Opin Allergy Clin Immunol2022
35197435Resolving the genetics of human tryptases: implications for health, disease, and clinical use as a biomarker.Curr Opin Allergy Clin Immunol2022
33865872Small intestinal immunopathology and GI-associated antibody formation in hereditary alpha-tryptasemia.J Allergy Clin Immunol2021
33865872Small intestinal immunopathology and GI-associated antibody formation in hereditary alpha-tryptasemia.J Allergy Clin Immunol2021
30948489Oncogenic D816V-KIT signaling in mast cells causes persistent IL-6 production.Haematologica2020
32369445Impaired angiogenesis and extracellular matrix metabolism in autosomal-dominant hyper-IgE syndrome.J Clin Invest2020
32769710Hymenoptera venom-induced anaphylaxis and hereditary alpha-tryptasemia.Curr Opin Allergy Clin Immunol2020
30948489Oncogenic D816V-KIT signaling in mast cells causes persistent IL-6 production.Haematologica2020
32769710Hymenoptera venom-induced anaphylaxis and hereditary alpha-tryptasemia.Curr Opin Allergy Clin Immunol2020
32369445Impaired angiogenesis and extracellular matrix metabolism in autosomal-dominant hyper-IgE syndrome.J Clin Invest2020
31102699GATA-2-deficient mast cells limit IgE-mediated immediate hypersensitivity reactions in human subjects.J Allergy Clin Immunol2019
31102699GATA-2-deficient mast cells limit IgE-mediated immediate hypersensitivity reactions in human subjects.J Allergy Clin Immunol2019
28710273PD-L1 up-regulation restrains Th17 cell differentiation in <i>STAT3</i> loss- and <i>STAT1</i> gain-of-function patients.J Exp Med2017
28710273PD-L1 up-regulation restrains Th17 cell differentiation in <i>STAT3</i> loss- and <i>STAT1</i> gain-of-function patients.J Exp Med2017
28289052Correction: ERBIN deficiency links STAT3 and TGF-β pathway defects with atopy in humans.J Exp Med2017
28126831ERBIN deficiency links STAT3 and TGF-β pathway defects with atopy in humans.J Exp Med2017
28126831ERBIN deficiency links STAT3 and TGF-β pathway defects with atopy in humans.J Exp Med2017
28289052Correction: ERBIN deficiency links STAT3 and TGF-β pathway defects with atopy in humans.J Exp Med2017
26948077Diminution of signal transducer and activator of transcription 3 signaling inhibits vascular permeability and anaphylaxis.J Allergy Clin Immunol2016
27383789Corrigendum: sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance.Nature2016
27042933sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance.Nature2016
26948077Diminution of signal transducer and activator of transcription 3 signaling inhibits vascular permeability and anaphylaxis.J Allergy Clin Immunol2016
27749843Elevated basal serum tryptase identifies a multisystem disorder associated with increased TPSAB1 copy number.Nat Genet2016
27749843Elevated basal serum tryptase identifies a multisystem disorder associated with increased TPSAB1 copy number.Nat Genet2016
27383789Corrigendum: sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance.Nature2016
27042933sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance.Nature2016
25359994Early-onset lymphoproliferation and autoimmunity caused by germline STAT3 gain-of-function mutations.Blood2015
25407936Wnt5A promotes an adaptive, senescent-like stress response, while continuing to drive invasion in melanoma cells.Pigment Cell Melanoma Res2015
25359994Early-onset lymphoproliferation and autoimmunity caused by germline STAT3 gain-of-function mutations.Blood2015
25407936Wnt5A promotes an adaptive, senescent-like stress response, while continuing to drive invasion in melanoma cells.Pigment Cell Melanoma Res2015
24650043Meeting report from the 10th International Congress of the Society for Melanoma Research, Philadelphia, PA, November 2013.Pigment Cell Melanoma Res2014
24650043Meeting report from the 10th International Congress of the Society for Melanoma Research, Philadelphia, PA, November 2013.Pigment Cell Melanoma Res2014
23303179Cyclophilin D extramitochondrial signaling controls cell cycle progression and chemokine-directed cell motility.J Biol Chem2013
24030649Change is in the air: the hypoxic induction of phenotype switching in melanoma.J Invest Dermatol2013
24104062Hypoxia induces phenotypic plasticity and therapy resistance in melanoma via the tyrosine kinase receptors ROR1 and ROR2.Cancer Discov2013
23921130Metabolic stress regulates cytoskeletal dynamics and metastasis of cancer cells.J Clin Invest2013
23303179Cyclophilin D extramitochondrial signaling controls cell cycle progression and chemokine-directed cell motility.J Biol Chem2013
24104062Hypoxia induces phenotypic plasticity and therapy resistance in melanoma via the tyrosine kinase receptors ROR1 and ROR2.Cancer Discov2013
23921130Metabolic stress regulates cytoskeletal dynamics and metastasis of cancer cells.J Clin Invest2013
24030649Change is in the air: the hypoxic induction of phenotype switching in melanoma.J Invest Dermatol2013
22922842Clonal dominance of CD133+ subset population as risk factor in tumor progression and disease recurrence of human cutaneous melanoma.Int J Oncol2012
22922842Clonal dominance of CD133+ subset population as risk factor in tumor progression and disease recurrence of human cutaneous melanoma.Int J Oncol2012
20955350Loss of Klotho during melanoma progression leads to increased filamin cleavage, increased Wnt5A expression, and enhanced melanoma cell motility.Pigment Cell Melanoma Res2011
20955350Loss of Klotho during melanoma progression leads to increased filamin cleavage, increased Wnt5A expression, and enhanced melanoma cell motility.Pigment Cell Melanoma Res2011
21449913The cannabinoid receptor inverse agonist AM251 regulates the expression of the EGF receptor and its ligands via destabilization of oestrogen-related receptor α protein.Br J Pharmacol2011
21978367A spoonful of sugar makes the melanoma go: the role of heparan sulfate proteoglycans in melanoma metastasis.Pigment Cell Melanoma Res2011
21978367A spoonful of sugar makes the melanoma go: the role of heparan sulfate proteoglycans in melanoma metastasis.Pigment Cell Melanoma Res2011
21449913The cannabinoid receptor inverse agonist AM251 regulates the expression of the EGF receptor and its ligands via destabilization of oestrogen-related receptor α protein.Br J Pharmacol2011
19802008The orphan tyrosine kinase receptor, ROR2, mediates Wnt5A signaling in metastatic melanoma.Oncogene2010
19802008The orphan tyrosine kinase receptor, ROR2, mediates Wnt5A signaling in metastatic melanoma.Oncogene2010
  • 1 - 50 of 80

Recommended Authors

Institut National de la Sante et de la Recherche Medicale (INSERM) U
Career Start Year 2010
Number of shared co-authors 2
University of Navarra
Career Start Year 2010
Number of shared co-authors 1
Center for Cancer Research, National Cancer Institute
Career Start Year 2010
Number of shared co-authors 3
University Hospital Zurich
Career Start Year 2009
Number of shared co-authors 7
The University of Texas MD Anderson Cancer Center
Career Start Year 2007
Number of shared co-authors 4
National Center for Toxicological Research
Career Start Year 2006
Number of shared co-authors 7
University of Toronto
Career Start Year 2005
Number of shared co-authors 0
Universite Paris Cite, CNRS
Career Start Year 2002
Number of shared co-authors 0
Adelaide Medical School, University of Adelaide
Career Start Year 2002
Number of shared co-authors 2
Center for Cancer Research, National Cancer Institute
Career Start Year 2002
Number of shared co-authors 5
Netherlands Cancer Institute
Career Start Year 2001
Number of shared co-authors 2
Max Planck Institute of Molecular Cell Biology and Genetics
Career Start Year 2001
Number of shared co-authors 0
Princess Margaret Cancer Centre, University Health Network and University of Toronto
Career Start Year 2000
Number of shared co-authors 0
Department of Pharmaceutical Sciences, University of Toronto
Career Start Year 1999
Number of shared co-authors 0
INSERM U1021, Institut Curie, PSL Research University, Campus Universitaire
Career Start Year 1999
Number of shared co-authors 2
Western University
Career Start Year 1999
Number of shared co-authors 0
Memorial Sloan Kettering Cancer Center
Career Start Year 1998
Number of shared co-authors 1
Thomas Jefferson University
Career Start Year 1996
Number of shared co-authors 7
College of Medicine, The Catholic University of Korea
Career Start Year 1996
Number of shared co-authors 0
Oncode Institute
Career Start Year 1993
Number of shared co-authors 0
Georgetown University Medical Center
Career Start Year 1991
Number of shared co-authors 1
Instituto do Cancer do Estado de Sao Paulo, Faculdade de Medicina de Sao Paulo
Career Start Year 1989
Number of shared co-authors 0
Amsterdam University Medical Center
Career Start Year 1989
Number of shared co-authors 0
Institut Curie, PSL Research University, INSERM U1021
Career Start Year 1987
Number of shared co-authors 5
Stanford University
Career Start Year 1985
Number of shared co-authors 0
Cutaneous Biology Research Center, Mass. General Hospital, Harvard Medical School
Career Start Year 1983
Number of shared co-authors 7
Ludwig Institute for Cancer Research, University of Oxford
Career Start Year 1983
Number of shared co-authors 1
Wellcome Sanger Institute
Career Start Year 1980
Number of shared co-authors 5
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1978
Number of shared co-authors 10
The University of Texas MD Anderson Cancer Center
Career Start Year 1975
Number of shared co-authors 1

Collaborators

Sidney Kimmel Cancer Center, Johns Hopkins School of Medicine
Co-authored papers 23
Columbia University
Co-authored papers 9
National Institute of Allergy and Infectious Diseases
Co-authored papers 5
University of Pennsylvania, Perelman School of Medicine
Co-authored papers 4
UCL Queen Square Institute of Neurology
Co-authored papers 4
Perelman School of Medicine, the University of Pennsylvania
Co-authored papers 4
National Institute on Aging, National Institutes of Health
Co-authored papers 4
The Wistar Institute
Co-authored papers 4
Co-authored papers 3
Center for Cancer Research, National Cancer Institute
Co-authored papers 3
Cincinnati Children's Hospital Medical Center
Co-authored papers 3
National Institute on Aging, National Institutes of Health
Co-authored papers 2
University of California Los Angeles (university of california los angeles)
Co-authored papers 2
Co-authored papers 2
Co-authored papers 2
Co-authored papers 2
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Co-authored papers 2
University Hospital of Zurich
Co-authored papers 2
Co-authored papers 2
Ellen and Ronald Caplan Cancer Center, The Wistar Institute
Co-authored papers 2
University of Pennsylvania
Co-authored papers 2
Co-authored papers 2
Yale School of Medicine
Co-authored papers 2
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 1
National Human Genome Research Institute, National Institutes of Health
Co-authored papers 1
Lehigh Valley Topper Cancer Institute
Co-authored papers 1
Arkansas Children's Research Institute
Co-authored papers 1
The Wistar Institute
Co-authored papers 1
Salish Kootenai College
Co-authored papers 1
Shanghai Center for Systems Biomedicine, Shanghai Jiao Tong University
Co-authored papers 1